NAUT · Nautilus Biotechnology, Inc. · Metrics
$1.45
+0.03 (+1.76%)
At close · Oct 1
Return incl. dividend (before tax)
Market Cap
$122.51M
Shares
127.26M
Volume · Oct 1
1.14M
Avg daily vol (3M)
1.49M
NAUT metrics
51 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$1.42
Market cap
$122.51M
Price action
20 metricsPrice change (1W)
+48.9%
Price change (30D)
+53.3%
Price change (3M)
-22.8%
Price change (6M)
-57.7%
Price change (YTD)
-27.2%
Price change (1Y)
+68.0%
Trailing year
Price change (5Y)
-76.9%
52-week high
$3.95
52-week low
$0.84
Change from 52-week high
-64.1%
Change from 52-week low
+70.1%
Annualized volatility
115.3%
Annualized volatility (3M)
115.6%
Beta
1.4
RSI (14D)
71.1
Price vs SMA 50
+38.1%
Price vs SMA 200
-31.5%
Avg volume (3M)
1.49M
Relative volume
8.6
Average dollar volume
$1.89M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
127.26M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
0.9
reciprocal yield 107.0%
FCF yield
-42.3%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-46.1%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-07-28
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
−$56.52M
Trailing 12 months
Diluted EPS (TTM)
$-0.45
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.7%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-43.1%
Return on assets
-34.6%
Debt / equity
—
Current ratio
10.1
EBITDA (TTM)
—
Free cash flow (TTM)
−$51.86M
Quick ratio
10.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$13.17M
Latest balance sheet
Cash & equivalents
$13.17M
Total assets
$163.58M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$50.23M
Capital expenditures (TTM)
$1.63M
R&D (TTM)
$38.50M
SG&A (TTM)
—
Stock compensation (TTM)
$5.49M
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
93
13F filer change QoQ
+10
Institutional ownership
39.4%
Short interest
3 metricsShort interest
3.2%
Latest settlement · 3.2 days to cover
Days to cover
3.2d
Short-squeeze score
77 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—